Uncovering novel therapeutic targets and identifying alternative practices to prevent or treat gastrointestinal diseases

The objective of the Gastrointestinal Stress Biology Laboratory is to gain a fundamental understanding of how stress, particularly early life stress, causes GI disease. The ultimate goal of our research is to uncover novel therapeutic targets and identify alternative practices to prevent or treat debilitating and economically devastating stress-related GI diseases.

Questions we are currently addressing in the GBS Laboratory:

  • How does early life stress/adversity influence the development of the ENS and immune system and what are the implications for lifelong GI disease susceptibility?
  • How are mast cells modulated by the stress response and how does this contribute to stress-related GI disorders?
  • Does Sex Matter? What role does biological sex play in mast cell biology and stress-related GI diseases?
  • How does stress influence GI nutrient transporter efficiency and nutrient utilization?
  • Can we mitigate the adverse impacts of stress on GI health in animals via new nutritional, therapeutic, or management strategies?
RESEARCH AREA 1

Regulation of mast cell degranulation and intestinal permeability by the corticotropin-releasing factor (CRF) system

Stress-related GI diseases, such as IBS, are characterized by increased mast cell numbers and heightened release of mast cell mediators (e.g. histamine, proteases, and TNF). Released mast cell products can impair intestinal barrier function and activate sensory neurons, which contribute to clinical signs of abdominal pain and diarrhea.

While the role of mast cells and their products in stress-induced intestinal disorders is known, very little is known about how mast cells are regulated during the stress response.

Previous work from our lab (Moeser 2006; Smith et al 2010; Overman et al 2010) and others (Wallon et al., 2008; Cao et al. 2006; Santos et al. 1996) have shown that a key stress response system that is linked with activation of intestinal mast cells and the CRF system. The CRF system is composed of two G-protein-coupled CRF receptors, CRF1 and CRF2, and their ligands CRF, and the related family of Urocortins (Ucn1-3). Precisely how the CRF system interacts with mast cells to provoke mast cell activation is poorly understood. A current area of research focus in this laboratory is to investigate how mast cells are regulated in response to psychological and immunological stressors via the CRF system.

RESEARCH AREA 2

Neuro-immune mechanisms of early-life stress-induced gastrointestinal disorders

Early-life adversity is a major risk factor for the later-life development and severity of major GI diseases including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) in adulthood.

The overall objective of this research is to understand the mechanisms by which early-life stress triggers long-lasting defects in intestinal epithelial barrier function.

The proposed studies will investigate the interactive signaling between the enteric cholinergic nervous system, intestinal mast cells, and the intestinal epithelial barrier utilizing novel pig and murine model systems. In addition, we aim to test the influence of sex on ENS development and mast cell function.

The project, based on previous studies and recent preliminary data, will test the hypothesis that early-life stress-associated GI disease is caused by a multi-step mechanism in which long-term sensitization and increased abundance of cholinergic enteric nerves triggers persistent mast cell activation and subsequent intestinal barrier dysfunction in a sex-dependent manner.

Understanding the early-life signaling pathways that trigger long-lasting intestinal barrier dysfunction and GI disease susceptibility will be critical in the development of new health management practices and therapies for important human GI diseases associated with early-life adversity.

At the same time, these studies will have significant relevance to understanding and treating GI diseases of agricultural animals, such as pigs, which undergo early-life production stressors that have long-lasting, deleterious influence on disease resistance, growth rate, and feed efficiency throughout the animal's production lifespan.

RESEARCH AREA 3

Optimizing gastrointestinal health in agricultural animals through basic science discovery, management, and nutrition

Disease in animals and people is a result of interactions between the host, environment, and pathogenic/immunologic factors. Interactions between the host with infectious pathogens and/or dysregulated metabolic and/or genetic factors are an essential part of the disease process. However, the presence of a pathogen or underlying risk factor alone is often insufficient to initiate disease due to the inherent epithelial and immunological defense barriers in the host. When animals (and people) are exposed to environmental stressors (e.g. psychological, nutrition, temperature, etc.), disease susceptibility is markedly increased. However, the biological mechanisms by which stress induces GI disease remain poorly understood and thus, targeted therapies remain limited.

We seek to (1) understand how environment and management-related stressors adversely impact GI health in animals and (2) develop and test new management strategies to prevent GI disease and improve animal well-being.

The impact of weaning stress on GI health in pigs

One major area of research in our laboratory is understanding how weaning stress impacts short- and long-term GI development and disease susceptibility and determine whether we can mitigate the adverse effects of weaning via management and dietary strategies. Weaning is the most stressful event a pig encounters during production. During weaning, the pig is faced with a multitude of concurrent stressors including maternal separation, diet changes, transport and commingling stress, and increased pathogen exposure (Madec et al., 1998). As a result, weaned pigs are more susceptible to intestinal dysfunction resulting in impaired growth and feed efficiency and increased susceptibility to infectious enteric pathogens. There are profound changes in the structure and function of the gut at weaning including a marked impairment in barrier function or increased permeability (Boudry et al., 2004; Moeser et al., 2007a), altered nutrient and electrolyte transport (Boudry et al., 2004; Moeser et al., 2007a), villus atrophy, and inflammation (Kelly et al., 1990; McCracken BA, 1999).

Although previous studies described above have focused on the short-term (1–2 weeks post-weaning) physiological and structural changes in the gut of the weaned pigs, we have accumulated extensive evidence that, depending on the degree of stress experienced at weaning, long-lasting alterations to intestinal function and pathogen defense are evident.

We demonstrated that weaning age has a significant impact on the severity of intestinal barrier injury induced by weaning. Specifically, we showed that weaning prior to 23 d of age induced a significant disruption in intestinal epithelial barrier function (increased intestinal permeability), increased electrogenic ion transport, and intestinal inflammation, compared with pigs weaned >23 d of age (Smith et al., 2010).

Further investigations revealed that the heightened intestinal injury in early-weaned pigs was independent of feed intake and systemic neuroendocrine responses (measured as serum CRF and cortisol (Moeser 2006). Instead, early weaning-induced intestinal barrier injury was shown to be mediated via activation of intestinal CRF receptors (Moeser et al. 2006).

In another study, McLamb et al. (2012) demonstrated that early-weaning stress in pigs resulted in increased clinical disease severity and intestinal injury in response to a later-life challenge with enterotoxigenic E. coli.

Taken together, our work has demonstrated that early-weaning stress induces lasting, deleterious changes to intestinal epithelial barrier and immune function resulting in increased stress sensitivity and disease severity. Our current investigations are aimed at defining the precise mechanisms by which stress lead to alterations in intestinal barrier and immune function and testing strategies (management and nutritional) to prevent and/or ameliorate stress-induced GI dysfunction.

Taken together, our work has demonstrated that early weaning stress induces lasting, deleterious changes to intestinal epithelial barrier and immune function resulting in increased stress sensitivity and disease severity. Our current investigations are aimed at defining the precise mechanisms by which stress lead to alterations in intestinal barrier and immune function and testing strategies (management and nutritional) to prevent and(or) ameliorate stress-induced GI dysfunction.